Table 1.
Antimicrobial activities of cultured sponge bacteria using deferred antagonism assays. 1 Bacillus cereus FPL1; 2 Bacillus subtilis 1A40; 3 B. subtilis 1E32; a hVISA (Heterogonous Vancomycin Intermediate Staphylococcus aureus) 22900; b MRSA (Methicillin resistant S. aureus) ST544; C VISA (Vancomycin intermediate S. aureus) 35403; d S. aureus NCIMB 9518: ‘+’ = positive. ‘−’ = negative; n.d. not determined. * adapted from Kennedy et al., 2009 [19].
| Test Strain | Gram Negative Bacteria | Gram Positive Bacteria | Yeasts | ||||
|---|---|---|---|---|---|---|---|
| E. coli NCIMB 12210 | P. aeruginosa PAO1 | Bacillus pp. | Staphylococcus spp. | L. monocyte genes F2365 | Candida spp. | A. fumigatus ATCC 46645 | |
| SM1 * | + | − | + 1,2 | + a | + | + | n.d. |
| SM5 * | + | − | + 1,2 | + a | − | − | n.d. |
| SM9 * | + | − | − | − | − | − | n.d. |
| SM10 * | + | n.d. | − | − | − | − | n.d. |
| SM11 * | − | − | + 2 | + a,b | − | − | n.d. |
| SM12 * | − | + | − | + a | − | − | n.d. |
| SM14 * | − | − | + 1,2 | + a | − | − | n.d. |
| SM16 * | − | + | + 2 | + c | − | − | n.d. |
| SM17 * | + | − | − | + b | − | + | n.d. |
| SM18 * | − | − | + 2 | + b | − | − | n.d. |
| FMC008 * | − | + | + 2 | + d | − | − | n.d. |
| B226SN101 | − | − | − 3 | − | n.d. | + | + |
| B188M101 | − | − | − 3 | − | n.d. | + | + |